In GSE57338, the six candidate biomarkers demonstrated significant differences between HF and normal samples (P < 0.05), with CD163, FPR1, and VSIG4 showing decreased expression in HF samples (Figure 4a). This evidence concerns the gene VSIG4 and hydrops fetalis.